SlideShare a Scribd company logo
ENTERAL NUTRITION CAN BE GIVEN TO PATIENTS ON
VASOPRESSORS
PRESENTOR: Dr. Kanika Chaudhary
OVERVIEW
 Introduction
 The Consequences of Circulatory Shock on Gut Barrier and Immune Functions
 The Consequences of Circulatory Shock and Critical Illness on the Gut Microbiota
 Benefits of Enteral Nutrition
 Recommendations
 Evidences based on recent studies
 Conclusion and Future Insight
 References
INTRODUCTION
Critically ill patients are often hemodynamically unstable (or at risk of becoming
unstable) owing to hypovolemia, cardiac dysfunction, or alterations of vasomotor
function, leading to organ dysfunction, deterioration into multiorgan failure, and
eventually death.
Under resting and normal conditions, around 25% of cardiac output is located in the
splanchnic circulation. Shock is characterized by blood flow redistribution with
vasoconstriction at splanchnic circulatory level and in peripheral tissues, in an attempt
to maintain vital organs perfusion. This can give rise to an imbalance in the oxygen
supply/demand ratio at intestinal level, with resulting ischemia. The reported incidence
ranges between 0.3% and 8.5%, with mortality ranging from 46% to 100%.
 Enteral Nutrition Therapy (ENT) is part of the essential care of patients in the intensive
care unit (ICU). It is recommended, due to several studies that demonstrate better
outcomes, that nutritional support should be started 24 to 48 hours after admission to the
ICU, since the patient has been resuscitated and with hemodynamic stability.
 ENT, when applied properly and early at the correct time, reduces the incidence of
unfavourable outcomes in critically ill patients as well as the risk of infectious
complications and ICU length of stay.
The Consequences of Circulatory Shock on Gut Barrier and Immune Functions
 Circulatory shock reduced effective circulating blood volume hypotension reduced oxygen
deliverywidespread cellular and tissue hypoxia ensue.
 Small intestine villous blood flows in opposite directions: arterial blood flows upwards towards the villus
and venous blood flows towards the base. Oxygen is extracted as blood moves towards the villus.
 Early in shock, blood flow is diverted away from non-vital organs, such as the gut, to preferentially perfuse
vital organs like the brain, heart, and kidneysreduces splanchnic blood flowdiminishes oxygen
delivered to the villus tip, leaving it susceptible to ischemia.
 Also, critical illness pathophysiology and processes accelerate enterocyte apoptosis and impair mucosal
integrity, resulting in breakdown of barrier defense. As a result, toxic mediators are transported into the
systemic circulation through lymphatic channels and create downstream organ dysfunction like acute
respiratory distress syndrome (ARDS).
 In healthy individuals, tight junctions (TJ) link enterocytes and are selectively permeable to prevent
the unregulated passage of intraluminal contents. Claudins, MARVEL domain proteins (occludin
and tricellulin) and junctional adhesion molecules are common to all tight junctions. Zona
occludens (ZO) proteins help link TJs to the cytoskeleton.
 Many components of the tight junction are altered in circulatory shock. Bacterial activation of
myosin light chain kinase (MLCK) causes contraction of the actin–myosin ring and increases
permeability at the cell–cell junction.
 Systemic inflammation induced reduced expression of claudin or occludin proteins allow for
bacterial adherence, which increases permeability.
 Vermette et al. reviewed 15 studies and concluded (a.) serum and urine levels of claudins-2,3 and 4
correlated with severity of acute gastrointestinal injury, (b.) serum ZO-1 best stratified sepsis
severity and degree of organ dysfunction, and (c.) urinary claudins were a reliable measure of early
gastrointestinal injury.
The Consequences of Circulatory Shock and Critical Illness on the Gut Microbiota
 Commensal organisms live in symbiosis with their host. The combination of commensal (nonvirulent)
organisms, IgA, thick mucus layer, an acidic gastric environment, and peristalsis resist pathogenic
bacterial colonization.
 Critical illness pathophysiologic processes and clinical interventions alter the gut ecological system to
(a.) increase microbial immigration,
(b.) impair microbial clearance
(c.) change environmental growth conditions
 Gut hypoperfusion impairs mucosal integrity to increase bacterial and their product elimination through
mesenteric lymphatics (alters microbial elimination) and increases mucosal inflammation (changes
environmental growth condition).
 Clinical ICU interventions such as gastric acid suppression and diminished oral intake, further impair
microbial elimination and promote acid-intolerant bacteria and create stress condition of nutrient scarcity,
respectively. As a result, a healthy gut microbiota consisting of predominantly Firmicutes and
Bacteroidetes is decimated and replaced by pathogenic Proteobacteria.
 Altered mucosal oxygen gradient and thinning of the intestinal mucosal layer that occur in circulatory
shock favor Pseudomonas aeruginosa and Escherichia coli growth
 Perturbations of intestinal epithelial homeostasis in critical illness increased pro-inflammatory cytokine
production, gut barrier dysfunction, and cellular apoptosis multiple organ failurerapid change in the
microbiome, known as dysbiosis.
 Dysbiosis has numerous consequences for the host. Virulent pathogens interact with epithelium, with or
without invasion, and induce the release of mucosal-derived cytokines, which travel through mesenteric
lymphatics to perpetuate inflammation and generate multiple organ dysfunctions. Gut-induced
inflammation has been associated with more gastrointestinal complications, more organ dysfunction and
infections, and greater mortality rate.
Benefits of Enteral Nutrition
1) Maintaining structural/functional gut integrity, thus attenuating intestinal permeability
2) Attenuate oxidative stress and inflammatory response, while maintaining humoral
immune responses
3) Decreased bacterial translocation
4) Modulation of metabolism to decrease insulin resistance
5) In endotoxic and septic shock, enteral feeding improved hepatic artery and portal vein
blood flow, superior mesenteric artery blood flow, intestinal mucosal microcirculatory flow,
hepatic microcirculatory flow, hepatic and intestinal tissue oxygenation, and hepatic energy
store
6) EN promotes enterocyte secretion of mucin-2 protein, which maintains a mucus layer
and helps flush pathogens, and resistin-like molecule-b secretion into the submucosa,
which pro motes CD-4 T cell recruitment driving host defense mechanisms including
epithelial cell proliferation.
7) EN promotes commensal bacteria to protect against enteric pathogens by (a.) direct
competition for nutrients,(b.) production of antibacterial peptides, and (c.) bile salt
modification rendering them harmful to other microorganisms
and driving mucus production.
8) Better clinical outcomes were observed, such as improved wound healing reducing the
severity of illness, complications, and ICU Length of stay (LOS)
RECOMMENDATIONS
 2016 Surviving Sepsis Campaign: International Guidelines for Management of Sepsis
and Septic Shock
1. We suggest the early initiation of enteral feeding rather than a complete fast or only
IV glucose in critically ill patients with sepsis or septic shock who can be fed
enterally.
(weak recommendation, low quality of evidence)
2. We suggest either early trophic/hypocaloric or early full enteral feeding in critically
ill patients with sepsis or septic shock; if trophic/hypocaloric feeding is the initial
strategy, then feeds should be advanced according to patient tolerance.
(weak recommendation, moderate quality of evidence)
 2016 Guidelines for the Provision and Assessment of Nutrition Support Therapy
in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and
American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.)
1. We recommend that nutrition support therapy in the form of early EN be initiated
within 24–48 hours in the critically ill patient who is unable to maintain volitional
intake.
(Quality of Evidence: Very Low)
1. If oral intake is not possible, early EN (within 48 h) in critically ill adult patients
should be performed/initiated rather than delaying EN
Grade of recommendation: B-strong consensus (100% agreement)
2. If oral intake is not possible, early EN (within 48 h) shall be performed/initiated in
critically ill adult patients rather than early PN
Grade of recommendation: A-strong consensus (100% agreement)
 2019 ESPEN guideline on clinical nutrition in the Intensive care unit
EVIDENCES BASED ON RECENT STUDIES
Krezalek MA, Yeh A, Alverdy JC, et al: Influence of nutrition therapy on the
intestinal microbiome. Curr Opin Clin Nutr Metab Care 2017;20:131–137
Provision of even 20% of nutrition via EN can prevent dysbiosis, attenuate loss
of gut barrier function, and innate immunity
EN can trigger activation of anti-inflammatory vagal-cholinergic pathway via
Cholecystokinin-mediated receptor stimulation in shock states
Lubbers T, de Haan JJ, Luyer MD, et al: Cholecystokinin/cholecystokinin-1
receptor-mediated peripheral activation of the afferent vagus by enteral nutrients
attenuates inflammation in rats. Ann Surg 2010;
252:376–382
Observational studies since 2017 primarily evaluating early enteral nutrition (EN) in shock
Randomized controlled studies since 2017 primarily evaluating early enteral nutrition (EN) in shock
EFFECT OF VASOPRESSORS ON DIGESTIVE SYSTEM CIRCULATION
EFFECT OF VASOPRESSORS ON DIGESTIVE SYSTEM CIRCULATION
CONCLUSIONS AND FUTURE INSIGHT
• Circulatory shock turns on the ‘‘gut motor,’’ which perpetuates inflammation through loss
of TJ integrity and bacterial dysbiosis, which generate dysregulated immune responses.
• Early EN, may maintain enterocyte barrier function and provide substrate for bacteria to
limit dysbiosis to prevent dysregulated immune responses.
• Recent observational and RCT data show early EN is well-tolerated and safe whereby the
incidence of NOMI and NOBN is low.
• Emerging observational and pilot RCT data suggest benefit from early EN in shock.
• Large-scale RCTs comparing different EN doses in circulatory shock are lacking.
• Future research testing the role of EN in shock is needed to identify optimal EN timing,
dose, and composition.
TAKE HOME MESSAGE
REFERENCES
• Wischmeyer PE. Enteral Nutrition Can Be Given to Patients on Vasopressors. Crit Care Med. 2020
Jan;48(1):122-125. doi: 10.1097/CCM.0000000000003965. PMID: 31414992
• Simo Es Covello LH, Gava-Brandolis MG, Castro MG, Dos Santos Netos MF, Manzanares W, Toledo
DO. Vasopressors and Nutrition Therapy: Safe Dose for the Outset of Enteral Nutrition? Crit Care Res
Pract. 2020 Feb 10;2020:1095693. doi: 10.1155/2020/1095693. PMID: 32104602; PMCID:
PMC7035530.
• Barash, M., Patel, J.J. Gut Luminal and Clinical Benefits of Early Enteral Nutrition in Shock. Curr
Surg Rep 7, 21 (2019)
• Krezalek MA, Yeh A, Alverdy JC, et al: Influence of nutrition therapy on the intestinal microbiome.
Curr Opin Clin Nutr Metab Care 2017; 20:131–137
• Bruns BR, Kozar RA: Feeding the postoperative patient on vasopressor support: Feeding and pressor
support. Nutr Clin Pract 2016;31:14–17
• Merchan C, Altshuler D, Aberle C, et al: Tolerability of enteral nutrition in mechanically ventilated
patients with septic shock who require vasopressors. J Intensive Care Med 2017; 32:540–546
• Ohbe H, Jo T, Matsui H, Fushimi K, Yasunaga H. Differences in effect of early enteral nutrition on
mortality among ventilated adults with shock requiring low-, medium-, and high-dose noradrenaline: a
propensity-matched analysis. Clin Nutr. 2019.
• Ohbe H, Jo T, Yamana H, Matsui H, Fushimi K, Yasunaga H. Early enteral nutrition for cardiogenic or
obstructive shockrequiring venoarterial extracorporeal membrane oxygenation: a nationwide inpatient
database study. Intensive Care Med.2018;44(8):1258–65.
• Ewy M, Aqeel M, Kozeniecki M, et al. The impact of enteral feeding on vasoactive support in septic
shock: a retrospective observational study. Aspen nutrition science and practice conference:Phoenix,
Arizona, March 23–26, 2019. J Parenter Enter Nutr. 2019;43:445.
• Patel JJ, Kozeniecki M, Peppard WJ, Peppard SR, Zellner-Jones S, Graf J, Szabo A, Heyland D. A phase
III pilot randomized controlled trial comparing early trophic enteral nutrition to ‘No Enteral Nutrition’ in
mechanically ventilated patients with septic shock. American society of parenteral and enteral nutrition
2019 nutrition science and practice conference, 2019, Phoenix,Arizona.
REFERENCES
• Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and
Septic Shock: 2016
• 2016 Guidelines for the Provision and Assessment of Nutrition Support Therapy in the
Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American
Society for Parenteral and Enteral Nutrition (A.S.P.E.N.)
• 2019 ESPEN guideline on clinical nutrition in the Intensive care unit
REFERENCES
THANK YOU

More Related Content

Similar to EN and Vasopressors.pptx

Research Progress of Intestinal Flora and High Fat Diet Obesity
Research Progress of Intestinal Flora and High Fat Diet ObesityResearch Progress of Intestinal Flora and High Fat Diet Obesity
Research Progress of Intestinal Flora and High Fat Diet Obesity
JohnJulie1
 
LEAKY GUT Intestinal permeability
LEAKY GUT  Intestinal permeabilityLEAKY GUT  Intestinal permeability
LEAKY GUT Intestinal permeability
Ellen Kamhi, PhD, RN, AHG, AHN-BC
 
Ankylosing Spondylitis the gut and the bugs: an integrative approach to treat...
Ankylosing Spondylitis the gut and the bugs: an integrative approach to treat...Ankylosing Spondylitis the gut and the bugs: an integrative approach to treat...
Ankylosing Spondylitis the gut and the bugs: an integrative approach to treat...
IFSMED
 
Perspectives 29 Treating a Patient with an Intestinal Obstruction
Perspectives 29 Treating a Patient with an Intestinal ObstructionPerspectives 29 Treating a Patient with an Intestinal Obstruction
Perspectives 29 Treating a Patient with an Intestinal Obstruction
tourtt
 
PEPTIC ULCER DISEASE AND RELATED DISORDERS.docx
PEPTIC ULCER DISEASE AND RELATED DISORDERS.docxPEPTIC ULCER DISEASE AND RELATED DISORDERS.docx
PEPTIC ULCER DISEASE AND RELATED DISORDERS.docx
GioBalisi1
 
Probiotics in Adult Gastroenterology
Probiotics in Adult GastroenterologyProbiotics in Adult Gastroenterology
Probiotics in Adult Gastroenterologynutritionistrepublic
 
colon targetting
colon targettingcolon targetting
colon targetting
ROHIT
 
Cystic Fibrosis "Overview of Gastrointestinal Diseases"
Cystic Fibrosis "Overview of Gastrointestinal Diseases"Cystic Fibrosis "Overview of Gastrointestinal Diseases"
Cystic Fibrosis "Overview of Gastrointestinal Diseases"Mahmoud Alaaeldin Hashim, MD.
 
Non neoplastic disorders of esophagus
Non neoplastic disorders of esophagusNon neoplastic disorders of esophagus
Non neoplastic disorders of esophagus
Vas Kannan
 
Small bowel fisulas & short bowel syndrome.pptx
Small bowel fisulas & short bowel syndrome.pptxSmall bowel fisulas & short bowel syndrome.pptx
Small bowel fisulas & short bowel syndrome.pptx
mamoon_saleh
 
4. Small bowel fisulas & short bowel syndrome.pptx
4. Small bowel fisulas & short bowel syndrome.pptx4. Small bowel fisulas & short bowel syndrome.pptx
4. Small bowel fisulas & short bowel syndrome.pptx
Mamoon Saleh
 
GASBARRINI A. Nutrizione Clinica e Gastroenterologia. ASMaD 2017
GASBARRINI A. Nutrizione Clinica e Gastroenterologia. ASMaD 2017GASBARRINI A. Nutrizione Clinica e Gastroenterologia. ASMaD 2017
GASBARRINI A. Nutrizione Clinica e Gastroenterologia. ASMaD 2017
Gianfranco Tammaro
 
Entero Cutaneous Fistula by Dr. Onkar
Entero Cutaneous Fistula by Dr. OnkarEntero Cutaneous Fistula by Dr. Onkar
Entero Cutaneous Fistula by Dr. Onkarguesta40423
 
Inflammatory bowel disease
Inflammatory bowel diseaseInflammatory bowel disease
Inflammatory bowel disease
Ruchita Bhavsar
 
inflammatoryboweldisease-170427143138.pdf
inflammatoryboweldisease-170427143138.pdfinflammatoryboweldisease-170427143138.pdf
inflammatoryboweldisease-170427143138.pdf
ShaliniN51
 
PEPTIC ULCER PATHOPHYSIOLOGY B.PHARM 2ND SEM.pptx
PEPTIC ULCER PATHOPHYSIOLOGY B.PHARM 2ND SEM.pptxPEPTIC ULCER PATHOPHYSIOLOGY B.PHARM 2ND SEM.pptx
PEPTIC ULCER PATHOPHYSIOLOGY B.PHARM 2ND SEM.pptx
subham404717
 
short bowel syndrome.pptx Dr. Tarimo BM UDSM MCHAS 2023
short bowel syndrome.pptx  Dr. Tarimo BM UDSM MCHAS 2023short bowel syndrome.pptx  Dr. Tarimo BM UDSM MCHAS 2023
short bowel syndrome.pptx Dr. Tarimo BM UDSM MCHAS 2023
BarakaTarimo1
 

Similar to EN and Vasopressors.pptx (20)

Research Progress of Intestinal Flora and High Fat Diet Obesity
Research Progress of Intestinal Flora and High Fat Diet ObesityResearch Progress of Intestinal Flora and High Fat Diet Obesity
Research Progress of Intestinal Flora and High Fat Diet Obesity
 
LEAKY GUT Intestinal permeability
LEAKY GUT  Intestinal permeabilityLEAKY GUT  Intestinal permeability
LEAKY GUT Intestinal permeability
 
Ankylosing Spondylitis the gut and the bugs: an integrative approach to treat...
Ankylosing Spondylitis the gut and the bugs: an integrative approach to treat...Ankylosing Spondylitis the gut and the bugs: an integrative approach to treat...
Ankylosing Spondylitis the gut and the bugs: an integrative approach to treat...
 
Perspectives 29 Treating a Patient with an Intestinal Obstruction
Perspectives 29 Treating a Patient with an Intestinal ObstructionPerspectives 29 Treating a Patient with an Intestinal Obstruction
Perspectives 29 Treating a Patient with an Intestinal Obstruction
 
PEPTIC ULCER DISEASE AND RELATED DISORDERS.docx
PEPTIC ULCER DISEASE AND RELATED DISORDERS.docxPEPTIC ULCER DISEASE AND RELATED DISORDERS.docx
PEPTIC ULCER DISEASE AND RELATED DISORDERS.docx
 
Pancreatitis en niños
Pancreatitis en niñosPancreatitis en niños
Pancreatitis en niños
 
Probiotics in Adult Gastroenterology
Probiotics in Adult GastroenterologyProbiotics in Adult Gastroenterology
Probiotics in Adult Gastroenterology
 
colon targetting
colon targettingcolon targetting
colon targetting
 
Cystic Fibrosis "Overview of Gastrointestinal Diseases"
Cystic Fibrosis "Overview of Gastrointestinal Diseases"Cystic Fibrosis "Overview of Gastrointestinal Diseases"
Cystic Fibrosis "Overview of Gastrointestinal Diseases"
 
peptic ulcer
peptic ulcerpeptic ulcer
peptic ulcer
 
Non neoplastic disorders of esophagus
Non neoplastic disorders of esophagusNon neoplastic disorders of esophagus
Non neoplastic disorders of esophagus
 
Article 031
Article 031Article 031
Article 031
 
Small bowel fisulas & short bowel syndrome.pptx
Small bowel fisulas & short bowel syndrome.pptxSmall bowel fisulas & short bowel syndrome.pptx
Small bowel fisulas & short bowel syndrome.pptx
 
4. Small bowel fisulas & short bowel syndrome.pptx
4. Small bowel fisulas & short bowel syndrome.pptx4. Small bowel fisulas & short bowel syndrome.pptx
4. Small bowel fisulas & short bowel syndrome.pptx
 
GASBARRINI A. Nutrizione Clinica e Gastroenterologia. ASMaD 2017
GASBARRINI A. Nutrizione Clinica e Gastroenterologia. ASMaD 2017GASBARRINI A. Nutrizione Clinica e Gastroenterologia. ASMaD 2017
GASBARRINI A. Nutrizione Clinica e Gastroenterologia. ASMaD 2017
 
Entero Cutaneous Fistula by Dr. Onkar
Entero Cutaneous Fistula by Dr. OnkarEntero Cutaneous Fistula by Dr. Onkar
Entero Cutaneous Fistula by Dr. Onkar
 
Inflammatory bowel disease
Inflammatory bowel diseaseInflammatory bowel disease
Inflammatory bowel disease
 
inflammatoryboweldisease-170427143138.pdf
inflammatoryboweldisease-170427143138.pdfinflammatoryboweldisease-170427143138.pdf
inflammatoryboweldisease-170427143138.pdf
 
PEPTIC ULCER PATHOPHYSIOLOGY B.PHARM 2ND SEM.pptx
PEPTIC ULCER PATHOPHYSIOLOGY B.PHARM 2ND SEM.pptxPEPTIC ULCER PATHOPHYSIOLOGY B.PHARM 2ND SEM.pptx
PEPTIC ULCER PATHOPHYSIOLOGY B.PHARM 2ND SEM.pptx
 
short bowel syndrome.pptx Dr. Tarimo BM UDSM MCHAS 2023
short bowel syndrome.pptx  Dr. Tarimo BM UDSM MCHAS 2023short bowel syndrome.pptx  Dr. Tarimo BM UDSM MCHAS 2023
short bowel syndrome.pptx Dr. Tarimo BM UDSM MCHAS 2023
 

More from Kanika Chaudhary

OXYGEN THERAPY.pptx
OXYGEN THERAPY.pptxOXYGEN THERAPY.pptx
OXYGEN THERAPY.pptx
Kanika Chaudhary
 
AKI.pptx
AKI.pptxAKI.pptx
SEPSIS.pptx
SEPSIS.pptxSEPSIS.pptx
SEPSIS.pptx
Kanika Chaudhary
 
Delirium.pptx
Delirium.pptxDelirium.pptx
Delirium.pptx
Kanika Chaudhary
 
TIF.pptx
TIF.pptxTIF.pptx
vasopressors.pptx
vasopressors.pptxvasopressors.pptx
vasopressors.pptx
Kanika Chaudhary
 
ENTERAL NUTRITION.pptx
ENTERAL NUTRITION.pptxENTERAL NUTRITION.pptx
ENTERAL NUTRITION.pptx
Kanika Chaudhary
 
ROSE CONCEPT.pptx
ROSE CONCEPT.pptxROSE CONCEPT.pptx
ROSE CONCEPT.pptx
Kanika Chaudhary
 
Shock
ShockShock
Thermoregulation
ThermoregulationThermoregulation
Thermoregulation
Kanika Chaudhary
 
Electrophysiology of heart
Electrophysiology of heartElectrophysiology of heart
Electrophysiology of heart
Kanika Chaudhary
 
Copd and anaesthetic management
Copd and anaesthetic managementCopd and anaesthetic management
Copd and anaesthetic management
Kanika Chaudhary
 

More from Kanika Chaudhary (12)

OXYGEN THERAPY.pptx
OXYGEN THERAPY.pptxOXYGEN THERAPY.pptx
OXYGEN THERAPY.pptx
 
AKI.pptx
AKI.pptxAKI.pptx
AKI.pptx
 
SEPSIS.pptx
SEPSIS.pptxSEPSIS.pptx
SEPSIS.pptx
 
Delirium.pptx
Delirium.pptxDelirium.pptx
Delirium.pptx
 
TIF.pptx
TIF.pptxTIF.pptx
TIF.pptx
 
vasopressors.pptx
vasopressors.pptxvasopressors.pptx
vasopressors.pptx
 
ENTERAL NUTRITION.pptx
ENTERAL NUTRITION.pptxENTERAL NUTRITION.pptx
ENTERAL NUTRITION.pptx
 
ROSE CONCEPT.pptx
ROSE CONCEPT.pptxROSE CONCEPT.pptx
ROSE CONCEPT.pptx
 
Shock
ShockShock
Shock
 
Thermoregulation
ThermoregulationThermoregulation
Thermoregulation
 
Electrophysiology of heart
Electrophysiology of heartElectrophysiology of heart
Electrophysiology of heart
 
Copd and anaesthetic management
Copd and anaesthetic managementCopd and anaesthetic management
Copd and anaesthetic management
 

Recently uploaded

ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
DR SETH JOTHAM
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 

Recently uploaded (20)

ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 

EN and Vasopressors.pptx

  • 1. ENTERAL NUTRITION CAN BE GIVEN TO PATIENTS ON VASOPRESSORS PRESENTOR: Dr. Kanika Chaudhary
  • 2. OVERVIEW  Introduction  The Consequences of Circulatory Shock on Gut Barrier and Immune Functions  The Consequences of Circulatory Shock and Critical Illness on the Gut Microbiota  Benefits of Enteral Nutrition  Recommendations  Evidences based on recent studies  Conclusion and Future Insight  References
  • 3. INTRODUCTION Critically ill patients are often hemodynamically unstable (or at risk of becoming unstable) owing to hypovolemia, cardiac dysfunction, or alterations of vasomotor function, leading to organ dysfunction, deterioration into multiorgan failure, and eventually death. Under resting and normal conditions, around 25% of cardiac output is located in the splanchnic circulation. Shock is characterized by blood flow redistribution with vasoconstriction at splanchnic circulatory level and in peripheral tissues, in an attempt to maintain vital organs perfusion. This can give rise to an imbalance in the oxygen supply/demand ratio at intestinal level, with resulting ischemia. The reported incidence ranges between 0.3% and 8.5%, with mortality ranging from 46% to 100%.
  • 4.  Enteral Nutrition Therapy (ENT) is part of the essential care of patients in the intensive care unit (ICU). It is recommended, due to several studies that demonstrate better outcomes, that nutritional support should be started 24 to 48 hours after admission to the ICU, since the patient has been resuscitated and with hemodynamic stability.  ENT, when applied properly and early at the correct time, reduces the incidence of unfavourable outcomes in critically ill patients as well as the risk of infectious complications and ICU length of stay.
  • 5. The Consequences of Circulatory Shock on Gut Barrier and Immune Functions  Circulatory shock reduced effective circulating blood volume hypotension reduced oxygen deliverywidespread cellular and tissue hypoxia ensue.  Small intestine villous blood flows in opposite directions: arterial blood flows upwards towards the villus and venous blood flows towards the base. Oxygen is extracted as blood moves towards the villus.  Early in shock, blood flow is diverted away from non-vital organs, such as the gut, to preferentially perfuse vital organs like the brain, heart, and kidneysreduces splanchnic blood flowdiminishes oxygen delivered to the villus tip, leaving it susceptible to ischemia.  Also, critical illness pathophysiology and processes accelerate enterocyte apoptosis and impair mucosal integrity, resulting in breakdown of barrier defense. As a result, toxic mediators are transported into the systemic circulation through lymphatic channels and create downstream organ dysfunction like acute respiratory distress syndrome (ARDS).
  • 6.  In healthy individuals, tight junctions (TJ) link enterocytes and are selectively permeable to prevent the unregulated passage of intraluminal contents. Claudins, MARVEL domain proteins (occludin and tricellulin) and junctional adhesion molecules are common to all tight junctions. Zona occludens (ZO) proteins help link TJs to the cytoskeleton.  Many components of the tight junction are altered in circulatory shock. Bacterial activation of myosin light chain kinase (MLCK) causes contraction of the actin–myosin ring and increases permeability at the cell–cell junction.  Systemic inflammation induced reduced expression of claudin or occludin proteins allow for bacterial adherence, which increases permeability.  Vermette et al. reviewed 15 studies and concluded (a.) serum and urine levels of claudins-2,3 and 4 correlated with severity of acute gastrointestinal injury, (b.) serum ZO-1 best stratified sepsis severity and degree of organ dysfunction, and (c.) urinary claudins were a reliable measure of early gastrointestinal injury.
  • 7. The Consequences of Circulatory Shock and Critical Illness on the Gut Microbiota  Commensal organisms live in symbiosis with their host. The combination of commensal (nonvirulent) organisms, IgA, thick mucus layer, an acidic gastric environment, and peristalsis resist pathogenic bacterial colonization.  Critical illness pathophysiologic processes and clinical interventions alter the gut ecological system to (a.) increase microbial immigration, (b.) impair microbial clearance (c.) change environmental growth conditions  Gut hypoperfusion impairs mucosal integrity to increase bacterial and their product elimination through mesenteric lymphatics (alters microbial elimination) and increases mucosal inflammation (changes environmental growth condition).  Clinical ICU interventions such as gastric acid suppression and diminished oral intake, further impair microbial elimination and promote acid-intolerant bacteria and create stress condition of nutrient scarcity, respectively. As a result, a healthy gut microbiota consisting of predominantly Firmicutes and Bacteroidetes is decimated and replaced by pathogenic Proteobacteria.
  • 8.  Altered mucosal oxygen gradient and thinning of the intestinal mucosal layer that occur in circulatory shock favor Pseudomonas aeruginosa and Escherichia coli growth  Perturbations of intestinal epithelial homeostasis in critical illness increased pro-inflammatory cytokine production, gut barrier dysfunction, and cellular apoptosis multiple organ failurerapid change in the microbiome, known as dysbiosis.  Dysbiosis has numerous consequences for the host. Virulent pathogens interact with epithelium, with or without invasion, and induce the release of mucosal-derived cytokines, which travel through mesenteric lymphatics to perpetuate inflammation and generate multiple organ dysfunctions. Gut-induced inflammation has been associated with more gastrointestinal complications, more organ dysfunction and infections, and greater mortality rate.
  • 9. Benefits of Enteral Nutrition 1) Maintaining structural/functional gut integrity, thus attenuating intestinal permeability 2) Attenuate oxidative stress and inflammatory response, while maintaining humoral immune responses 3) Decreased bacterial translocation 4) Modulation of metabolism to decrease insulin resistance 5) In endotoxic and septic shock, enteral feeding improved hepatic artery and portal vein blood flow, superior mesenteric artery blood flow, intestinal mucosal microcirculatory flow, hepatic microcirculatory flow, hepatic and intestinal tissue oxygenation, and hepatic energy store
  • 10. 6) EN promotes enterocyte secretion of mucin-2 protein, which maintains a mucus layer and helps flush pathogens, and resistin-like molecule-b secretion into the submucosa, which pro motes CD-4 T cell recruitment driving host defense mechanisms including epithelial cell proliferation. 7) EN promotes commensal bacteria to protect against enteric pathogens by (a.) direct competition for nutrients,(b.) production of antibacterial peptides, and (c.) bile salt modification rendering them harmful to other microorganisms and driving mucus production. 8) Better clinical outcomes were observed, such as improved wound healing reducing the severity of illness, complications, and ICU Length of stay (LOS)
  • 11. RECOMMENDATIONS  2016 Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 1. We suggest the early initiation of enteral feeding rather than a complete fast or only IV glucose in critically ill patients with sepsis or septic shock who can be fed enterally. (weak recommendation, low quality of evidence) 2. We suggest either early trophic/hypocaloric or early full enteral feeding in critically ill patients with sepsis or septic shock; if trophic/hypocaloric feeding is the initial strategy, then feeds should be advanced according to patient tolerance. (weak recommendation, moderate quality of evidence)
  • 12.  2016 Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) 1. We recommend that nutrition support therapy in the form of early EN be initiated within 24–48 hours in the critically ill patient who is unable to maintain volitional intake. (Quality of Evidence: Very Low)
  • 13. 1. If oral intake is not possible, early EN (within 48 h) in critically ill adult patients should be performed/initiated rather than delaying EN Grade of recommendation: B-strong consensus (100% agreement) 2. If oral intake is not possible, early EN (within 48 h) shall be performed/initiated in critically ill adult patients rather than early PN Grade of recommendation: A-strong consensus (100% agreement)  2019 ESPEN guideline on clinical nutrition in the Intensive care unit
  • 14. EVIDENCES BASED ON RECENT STUDIES
  • 15. Krezalek MA, Yeh A, Alverdy JC, et al: Influence of nutrition therapy on the intestinal microbiome. Curr Opin Clin Nutr Metab Care 2017;20:131–137 Provision of even 20% of nutrition via EN can prevent dysbiosis, attenuate loss of gut barrier function, and innate immunity
  • 16. EN can trigger activation of anti-inflammatory vagal-cholinergic pathway via Cholecystokinin-mediated receptor stimulation in shock states Lubbers T, de Haan JJ, Luyer MD, et al: Cholecystokinin/cholecystokinin-1 receptor-mediated peripheral activation of the afferent vagus by enteral nutrients attenuates inflammation in rats. Ann Surg 2010; 252:376–382
  • 17. Observational studies since 2017 primarily evaluating early enteral nutrition (EN) in shock
  • 18. Randomized controlled studies since 2017 primarily evaluating early enteral nutrition (EN) in shock
  • 19.
  • 20. EFFECT OF VASOPRESSORS ON DIGESTIVE SYSTEM CIRCULATION EFFECT OF VASOPRESSORS ON DIGESTIVE SYSTEM CIRCULATION
  • 21. CONCLUSIONS AND FUTURE INSIGHT • Circulatory shock turns on the ‘‘gut motor,’’ which perpetuates inflammation through loss of TJ integrity and bacterial dysbiosis, which generate dysregulated immune responses. • Early EN, may maintain enterocyte barrier function and provide substrate for bacteria to limit dysbiosis to prevent dysregulated immune responses. • Recent observational and RCT data show early EN is well-tolerated and safe whereby the incidence of NOMI and NOBN is low. • Emerging observational and pilot RCT data suggest benefit from early EN in shock. • Large-scale RCTs comparing different EN doses in circulatory shock are lacking. • Future research testing the role of EN in shock is needed to identify optimal EN timing, dose, and composition.
  • 23. REFERENCES • Wischmeyer PE. Enteral Nutrition Can Be Given to Patients on Vasopressors. Crit Care Med. 2020 Jan;48(1):122-125. doi: 10.1097/CCM.0000000000003965. PMID: 31414992 • Simo Es Covello LH, Gava-Brandolis MG, Castro MG, Dos Santos Netos MF, Manzanares W, Toledo DO. Vasopressors and Nutrition Therapy: Safe Dose for the Outset of Enteral Nutrition? Crit Care Res Pract. 2020 Feb 10;2020:1095693. doi: 10.1155/2020/1095693. PMID: 32104602; PMCID: PMC7035530. • Barash, M., Patel, J.J. Gut Luminal and Clinical Benefits of Early Enteral Nutrition in Shock. Curr Surg Rep 7, 21 (2019) • Krezalek MA, Yeh A, Alverdy JC, et al: Influence of nutrition therapy on the intestinal microbiome. Curr Opin Clin Nutr Metab Care 2017; 20:131–137 • Bruns BR, Kozar RA: Feeding the postoperative patient on vasopressor support: Feeding and pressor support. Nutr Clin Pract 2016;31:14–17 • Merchan C, Altshuler D, Aberle C, et al: Tolerability of enteral nutrition in mechanically ventilated patients with septic shock who require vasopressors. J Intensive Care Med 2017; 32:540–546
  • 24. • Ohbe H, Jo T, Matsui H, Fushimi K, Yasunaga H. Differences in effect of early enteral nutrition on mortality among ventilated adults with shock requiring low-, medium-, and high-dose noradrenaline: a propensity-matched analysis. Clin Nutr. 2019. • Ohbe H, Jo T, Yamana H, Matsui H, Fushimi K, Yasunaga H. Early enteral nutrition for cardiogenic or obstructive shockrequiring venoarterial extracorporeal membrane oxygenation: a nationwide inpatient database study. Intensive Care Med.2018;44(8):1258–65. • Ewy M, Aqeel M, Kozeniecki M, et al. The impact of enteral feeding on vasoactive support in septic shock: a retrospective observational study. Aspen nutrition science and practice conference:Phoenix, Arizona, March 23–26, 2019. J Parenter Enter Nutr. 2019;43:445. • Patel JJ, Kozeniecki M, Peppard WJ, Peppard SR, Zellner-Jones S, Graf J, Szabo A, Heyland D. A phase III pilot randomized controlled trial comparing early trophic enteral nutrition to ‘No Enteral Nutrition’ in mechanically ventilated patients with septic shock. American society of parenteral and enteral nutrition 2019 nutrition science and practice conference, 2019, Phoenix,Arizona. REFERENCES
  • 25. • Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 • 2016 Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) • 2019 ESPEN guideline on clinical nutrition in the Intensive care unit REFERENCES